HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.

AbstractBACKGROUND:
Elemental diet is considered an effective primary treatment for active Crohn's disease, but it is usually given by a feeding tube.
METHODS:
Twenty-two patients (12 males, median age 30 years, range 18-60) with moderately active Crohn's disease were enrolled in a randomized study in which the efficacy of an elemental diet administered orally was compared to high-dose corticosteroids in achieving clinical and laboratory remission. Ten patients were treated by oral elemental diet (Peptamen, Clintec, USA) and 10 received corticosteroids. Both treatment regimens lasted 2 weeks. The two groups did not differ with respect to age, sex, body weight, location of disease, treatment or disease activity prior to the study. In all patients studied, simple Crohn's disease activity index, nutritional status (expressed as body mass index), percentage of ideal body weight, fat mass, fat free mass, erythrocyte sedimentation rate, interleukin-6, intestinal permeability (expressed as permeability index), prealbumin, retinol binding protein and multiskin test were evaluated before and after treatment.
RESULTS:
After 2 weeks of treatment, there were significant improvements in simple Crohn's disease activity index, erythrocyte sedimentation rate, permeability index, body mass index, prealbumin, retinol binding protein and multiskin test in the elemental diet group. There were significant improvements in simple Crohn's disease activity index and fat free mass in the corticosteroid group.
CONCLUSIONS:
These data suggest that, in the short term, an oral elemental diet is at least as effective as steroids in inducing remission of mild-moderately active Crohn's disease, but it may be more effective in improving the nutritional status of these patients, probably through a more rapid restoration of normal intestinal permeability.
AuthorsG Zoli, M Carè, M Parazza, C Spanò, P L Biagi, M Bernardi, G Gasbarrini
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 11 Issue 4 Pg. 735-40 (Aug 1997) ISSN: 0269-2813 [Print] England
PMID9305483 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Prednisolone
Topics
  • Adolescent
  • Adult
  • Anti-Inflammatory Agents (therapeutic use)
  • Crohn Disease (diet therapy, drug therapy, pathology, therapy)
  • Female
  • Food, Formulated
  • Glucocorticoids (therapeutic use)
  • Humans
  • Intestinal Absorption
  • Male
  • Middle Aged
  • Nutritional Status
  • Prednisolone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: